RLYB-116
N/A
Report date: 2025/05/09 15:53:57
Base Information
Drug NameRLYB-116
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum (Sobi)Affibody Ab
China Registration ClassN/A
Develop Information
Active CompaniesIPC Research LLCRallybio Llc
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A